Cargando…

Association of CD166 expression with clinicopathologic characteristics of colorectal cancer

Detalles Bibliográficos
Autores principales:	Moslemi, Dariush, Mohammadianpanah, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913721/ https://www.ncbi.nlm.nih.gov/pubmed/27386070

Ejemplares similares

Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis
por: Han, Susu, et al.
Publicado: (2017)

Characteristics of the Patients With Colorectal Cancer: Epidemiologic Study or Pathology Report-Based Study
por: Mohammadianpanah, Mohammad
Publicado: (2014)

CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)

CD166-specific CAR-T cells potently target colorectal cancer cells
por: He, Shuai, et al.
Publicado: (2022)

ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012)

Commentary on "Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry"
por: Mohammadianpanah, Mohammad
Publicado: (2014)

Clinicopathological Characteristics of Newly Diagnosed Colorectal Cancers in Community Gastroenterology Practice
por: Lee, Chang Kyun
Publicado: (2014)

Expression and Role of CD166 in the Chronic Kidney Disease
por: Sun, Yan, et al.
Publicado: (2015)

Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells
por: Wong, Hung Lai, et al.
Publicado: (2018)

Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers
por: Jung, Soo-Jung, et al.
Publicado: (2020)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

CD166 expression in dentigerous cyst, keratocystic odontogenic tumor and ameloblastoma
por: Andisheh-Tadbir, Azadeh, et al.
Publicado: (2016)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Commentary on "Characteristics and Survival of Korean Anal Cancer From the Korea Central Cancer Registry Data"
por: Mohammadianpanah, Mohammad
Publicado: (2014)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
por: Kalantari, Elham, et al.
Publicado: (2022)

Clinicopathological characteristics of early onset colorectal cancer
por: Vuik, Fanny E. R., et al.
Publicado: (2021)

Clinicopathologic characteristics of early-onset colorectal cancer
por: Park, Kui Seon, et al.
Publicado: (2022)

Bertillón 166
por: Soler Puig, José, 1916-
Publicado: (1960)

Bertillón 166
por: Soler Puig, José
Publicado: (1960)

Bertillón 166
por: Soler Puig, José, 1916-
Publicado: (1987)

Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis
por: Ni, Chao, et al.
Publicado: (2013)

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)

Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction
por: Chappell, Paul E., et al.
Publicado: (2015)

Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer
por: Myint, Zin W., et al.
Publicado: (2023)

Oboensonate Opus 166 = Oboe sonata op. 166
por: Saint-Saëns, Camille, 1835-1921
Publicado: (2010)

Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma
por: Kaur, Gurjeet, et al.
Publicado: (2011)

Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features
por: Tian, Xiuyun, et al.
Publicado: (2015)

Small Cell Carcinoma of the Esophagus: Clinicopathological Features and Outcome of 22 Cases
por: Hosseini, Sare, et al.
Publicado: (2015)

ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
por: Brinkhof, Bas, et al.
Publicado: (2020)

Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer
por: Lee, Jae-Ho, et al.
Publicado: (2020)

Clinicopathological Significance of PTEN Expression and Its Prognostic Effect in Colorectal Adenocarcinoma Patients
por: Mirzapour Abbas Abadi, Zohreh, et al.
Publicado: (2022)

S166. Submission Withdrawn
Publicado: (2018)

IAU Colloquium No. 166
por: Breitschwerdt, Dieter, et al.
Publicado: (1998)

Memorandum: experiment S166
por: Brückner, W
Publicado: (1981)

CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells
por: Kim, Dae Kyoung, et al.
Publicado: (2020)

Expression of septin 2 and association with clinicopathological parameters in colorectal cancer
por: He, Haoyu, et al.
Publicado: (2019)

Analysis of G3BP1 and VEZT Expression in Gastric Cancer and Their Possible Correlation with Tumor Clinicopathological Factors
por: Beheshtizadeh, Mohammadreza, et al.
Publicado: (2017)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_25ho83dtgnll44opkvtbbkehon